ALPN-101 (Acazicolcept) in Systemic Lupus Erythematosus

Clinical trial NCT04835441 · COMPLETED

Trial details

NCT number: NCT04835441
Sponsor: Alpine Immune Sciences Inc, A Subsidiary of Vertex
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus

Start date: 2021-06-22
Primary completion: 2024-07-09
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.